Cargando…

Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study

BACKGROUND: The aim of the present study was to describe specific characteristics of patients suffering from pelvic fragility fractures and evaluate factors that might influence treatment decisions which may optimize treatment pathways and patient mobility in the future. METHODS: A prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberkircher, Ludwig, Lenz, Julia, Bücking, Benjamin, Eschbach, Daphne, Aigner, René, Bliemel, Christopher, Schoeneberg, Carsten, Ruchholtz, Steffen, Hack, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364046/
https://www.ncbi.nlm.nih.gov/pubmed/34388997
http://dx.doi.org/10.1186/s12891-021-04573-2
_version_ 1783738462346674176
author Oberkircher, Ludwig
Lenz, Julia
Bücking, Benjamin
Eschbach, Daphne
Aigner, René
Bliemel, Christopher
Schoeneberg, Carsten
Ruchholtz, Steffen
Hack, Juliana
author_facet Oberkircher, Ludwig
Lenz, Julia
Bücking, Benjamin
Eschbach, Daphne
Aigner, René
Bliemel, Christopher
Schoeneberg, Carsten
Ruchholtz, Steffen
Hack, Juliana
author_sort Oberkircher, Ludwig
collection PubMed
description BACKGROUND: The aim of the present study was to describe specific characteristics of patients suffering from pelvic fragility fractures and evaluate factors that might influence treatment decisions which may optimize treatment pathways and patient mobility in the future. METHODS: A prospective study with patients suffering from fractures of the pelvis and aged 60 years or above was performed between 2012 and 2016. Data acquisition took place at admission, every day during hospitalization and at discharge. RESULTS: One hundred thirty-four patients (mean age of 79.93 (± 7.67) years), predominantly female (84%), were included. Eighty-six patients were treated non-operatively. Forty-eight patients underwent a surgical procedure. The main fracture types were B2 fractures (52.24%) and FFP IIb fractures (39.55%). At the time of discharge, pain level (NRS) could be significantly reduced (p <  0.001). Patients who underwent a surgical procedure had a significantly higher pain level on day three and four compared to the non-operative group (p = 0.032 and p = 0.023, respectively). Significant differences were found in the mobility level: patients treated operatively on day four or later were not able to stand or walk on day three as compared to non-operatively treated patients. Regarding B2 fractures, a significantly higher mobility level difference between time of admission and discharge was found in patients treated with a surgical procedure compared to patients treated non-operatively (p = 0.035). CONCLUSIONS: Fracture type, mobility level and pain level influence the decision to proceed with surgical treatment. Especially patients suffering from B2 fractures benefitted in terms of mobility level at discharge when treated operatively. LEVEL OF EVIDENCE: II
format Online
Article
Text
id pubmed-8364046
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83640462021-08-17 Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study Oberkircher, Ludwig Lenz, Julia Bücking, Benjamin Eschbach, Daphne Aigner, René Bliemel, Christopher Schoeneberg, Carsten Ruchholtz, Steffen Hack, Juliana BMC Musculoskelet Disord Research BACKGROUND: The aim of the present study was to describe specific characteristics of patients suffering from pelvic fragility fractures and evaluate factors that might influence treatment decisions which may optimize treatment pathways and patient mobility in the future. METHODS: A prospective study with patients suffering from fractures of the pelvis and aged 60 years or above was performed between 2012 and 2016. Data acquisition took place at admission, every day during hospitalization and at discharge. RESULTS: One hundred thirty-four patients (mean age of 79.93 (± 7.67) years), predominantly female (84%), were included. Eighty-six patients were treated non-operatively. Forty-eight patients underwent a surgical procedure. The main fracture types were B2 fractures (52.24%) and FFP IIb fractures (39.55%). At the time of discharge, pain level (NRS) could be significantly reduced (p <  0.001). Patients who underwent a surgical procedure had a significantly higher pain level on day three and four compared to the non-operative group (p = 0.032 and p = 0.023, respectively). Significant differences were found in the mobility level: patients treated operatively on day four or later were not able to stand or walk on day three as compared to non-operatively treated patients. Regarding B2 fractures, a significantly higher mobility level difference between time of admission and discharge was found in patients treated with a surgical procedure compared to patients treated non-operatively (p = 0.035). CONCLUSIONS: Fracture type, mobility level and pain level influence the decision to proceed with surgical treatment. Especially patients suffering from B2 fractures benefitted in terms of mobility level at discharge when treated operatively. LEVEL OF EVIDENCE: II BioMed Central 2021-08-13 /pmc/articles/PMC8364046/ /pubmed/34388997 http://dx.doi.org/10.1186/s12891-021-04573-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Oberkircher, Ludwig
Lenz, Julia
Bücking, Benjamin
Eschbach, Daphne
Aigner, René
Bliemel, Christopher
Schoeneberg, Carsten
Ruchholtz, Steffen
Hack, Juliana
Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title_full Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title_fullStr Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title_full_unstemmed Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title_short Which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
title_sort which factors influence treatment decision in fragility fractures of the pelvis? - results of a prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364046/
https://www.ncbi.nlm.nih.gov/pubmed/34388997
http://dx.doi.org/10.1186/s12891-021-04573-2
work_keys_str_mv AT oberkircherludwig whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT lenzjulia whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT buckingbenjamin whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT eschbachdaphne whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT aignerrene whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT bliemelchristopher whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT schoenebergcarsten whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT ruchholtzsteffen whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy
AT hackjuliana whichfactorsinfluencetreatmentdecisioninfragilityfracturesofthepelvisresultsofaprospectivestudy